Company Monitoring Page for Mylan

latest headlines for company on cafepharma

Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Fierce Pharma
Wed, 02/5/20 - 10:25 pm
Tags:
Biogen, patents, Tecfidera, Mylan, multiple sclerosis, MS
Pfizer is bulking up its Mylan-Upjohn spinoff but investors may not reap rewards: analysts
Fierce Pharma
Wed, 01/29/20 - 11:57 pm
Tags:
Pfizer, Mylan, Upjohn, Viatris, China
Novartis gives up on Advair generic, leaving Mylan as sole competitor
BioPharma Dive
Wed, 01/29/20 - 11:52 pm
Tags:
Novartis, generics, Advair, Mylan
Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst
Fierce Pharma
Thu, 01/9/20 - 11:53 pm
Tags:
Pfizer, Upjohn, Mylan, spinoffs, generics
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Thu, 12/26/19 - 01:18 pm
Tags:
Pfizer, Bristol-Myers Squibb, FDA, generics, bloodthinners, Eliquis, Micro Labs, Mylan
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Fri, 12/6/19 - 09:54 am
Tags:
Novartis, FDA, Gilenya, MS, multiple sclerosis, Mylan, Dr Reddy's, Torrent Pharmaceuticals, Aurobindo, generics
Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio
Fierce Pharma
Tue, 12/3/19 - 10:02 am
Tags:
Roche, Mylan, Herceptin, biosimilar, cancer, oncology, Ogivri
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Fierce Pharma
Tue, 11/12/19 - 07:57 pm
Tags:
Mylan, Pfizer, Upjohn, M&A, generics, Viatris
Think Mylan's done with M&A after its Pfizer deal? Think again
Fierce Pharma
Tue, 11/5/19 - 11:49 pm
Tags:
Mylan, Pfizer, M&A, Upjohn, generics
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Mon, 11/4/19 - 07:33 pm
Tags:
Allergan, Regeneron, Mylan, Catalent, Jazz Pharmaceuticals
Thanks, Pfizer: Mylan execs in line for $71M-plus golden parachutes in Upjohn merger
Fierce Pharma
Tue, 10/29/19 - 10:53 pm
Tags:
Mylan, Pfizer, M&A, executive pay
Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal
Investors Business Daily
Sat, 09/28/19 - 05:16 pm
Tags:
Mylan, SEC, EpiPen
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Fierce Pharma
Tue, 09/3/19 - 10:24 am
Tags:
Mylan, Lantus, generics, Biocon, drug manufacturing, diabetes
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
BioSpace
Mon, 09/2/19 - 12:25 pm
Tags:
Eli Lilly, Mylan, Alimta, FDA, generics, lung cancer
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Pharmaforum
Fri, 08/30/19 - 10:48 am
Tags:
Mylan, Eli Lilly, generics, Alimta, non-squamous non-small cell lung cancer, mesothelioma
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Thu, 08/22/19 - 05:01 pm
Tags:
Novo Nordisk, Mylan, generics, Victoza, diabetes
3 generic drugmakers accused of 'stonewalling' congressional probe
Beckers Hospital Review
Thu, 08/15/19 - 10:41 am
Tags:
generics, Mylan, Teva Pharmaceutical, Heritage Pharmaceuticals
Mylan-Upjohn Merger Leaves Analysts Skeptical
Xtalks
Sat, 08/3/19 - 02:38 pm
Tags:
analysts, M&A, Mylan, Pfizer, Upjohn
After Mylan Gets Acquired, Could Teva Be Next?
Yahoo/Guru Focus
Sat, 08/3/19 - 12:57 pm
Tags:
Pfizer, Upjohn, Mylan, Teva Pharmaceutical, M&A
Pfizer may send EpiPen manufacturing to generics spinoff
Biopharma Dive
Fri, 08/2/19 - 12:18 am
Tags:
Pfizer, Mylan, M&A, Meridian Medical Technologies, EpiPens, drug shortages

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.